| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Revenue | $312K | -65.7% |
| Gross Profit | $614K | -32.5% |
| R&D Expense | $778K | — |
| SG&A Expense | $3.8M | +4165.8% |
| Operating Income | -$3.3M | — |
| Pre-tax Income | -$3.6M | +80.8% |
| Net Income | -$3.6M | +80.8% |
| EPS (Basic) | -$0.03 | +80.0% |
| EPS (Diluted) | -$0.03 | +70.0% |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $302K | +33.0% |
| Current Assets | $421K | -74.9% |
| Total Assets | $902K | -87.4% |
| Current Liabilities | $1.4M | +451.5% |
| Total Liabilities | $1.4M | +451.5% |
| Stockholders' Equity | -$521K | -107.6% |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.5M | +87.0% |
| Capital Expenditures | $2K | +0.0% |
| Investing Cash Flow | -$498K | +90.6% |
| Financing Cash Flow | $1.1M | -95.6% |
| Free Cash Flow | -$2.5M | +87.0% |